The University of Chicago Header Logo

Connection

Sean David to Smoking Cessation

Back to Details
This is a "connection" page, showing publications Sean David has written about Smoking Cessation.
Sean David
Connection Strength
6.548
Smoking Cessation
  1. Extended treatment for cigarette smoking cessation: a randomized control trial. Addiction. 2017 Aug; 112(8):1451-1459.
    View in: PubMed
    Score: 0.455
  2. Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016 06 29; 6(6):e010960.
    View in: PubMed
    Score: 0.429
  3. Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open. 2014 Mar 14; 4(3):e004393.
    View in: PubMed
    Score: 0.366
  4. Commentary on Chen et?al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation? Addiction. 2014 Jan; 109(1):138-9.
    View in: PubMed
    Score: 0.361
  5. Opioid antagonists for smoking cessation. Cochrane Database Syst Rev. 2013 Jun 06; (6):CD003086.
    View in: PubMed
    Score: 0.347
  6. Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. Nicotine Tob Res. 2011 Mar; 13(3):157-67.
    View in: PubMed
    Score: 0.295
  7. Genetic variation in the dopamine pathway and smoking cessation. Pharmacogenomics. 2008 Sep; 9(9):1307-21.
    View in: PubMed
    Score: 0.249
  8. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend. 2008 Nov 01; 98(1-2):77-85.
    View in: PubMed
    Score: 0.246
  9. Smoking cessation in primary care. BMJ. 2008 May 31; 336(7655):1200-1.
    View in: PubMed
    Score: 0.244
  10. Successful Latino community partnership program for smoking cessation. Am J Public Health. 2007 Aug; 97(8):1348-9; author reply 1349.
    View in: PubMed
    Score: 0.230
  11. Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J. 2008 Apr; 8(2):122-8.
    View in: PubMed
    Score: 0.226
  12. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
    View in: PubMed
    Score: 0.179
  13. Do medications increase the efficacy of digital interventions for smoking cessation? Secondary results from the iCanQuit randomized trial. Addiction. 2024 04; 119(4):664-676.
    View in: PubMed
    Score: 0.179
  14. Are family physicians willing to use pharmacogenetics for smoking cessation therapy? Fam Med. 2003 Feb; 35(2):83.
    View in: PubMed
    Score: 0.169
  15. No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics. 2002 Apr; 12(3):265-8.
    View in: PubMed
    Score: 0.160
  16. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2021 11 30; 11:CD011823.
    View in: PubMed
    Score: 0.156
  17. Should we recommend nicotine replacement therapy? Am Fam Physician. 2001 Jun 01; 63(11):2245-7.
    View in: PubMed
    Score: 0.151
  18. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence? Nicotine Tob Res. 2019 08 19; 21(9):1289-1293.
    View in: PubMed
    Score: 0.133
  19. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. Pharmacogenomics. 2018 07 01; 19(10):861-871.
    View in: PubMed
    Score: 0.123
  20. The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. Nicotine Tob Res. 2018 03 06; 20(4):403-413.
    View in: PubMed
    Score: 0.121
  21. Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. Nicotine Tob Res. 2018 03 06; 20(4):414-424.
    View in: PubMed
    Score: 0.121
  22. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database Syst Rev. 2017 09 08; 9:CD011823.
    View in: PubMed
    Score: 0.117
  23. Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 11; 14(11):1430-1468.
    View in: PubMed
    Score: 0.110
  24. Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial. J Gen Intern Med. 2016 Feb; 31(2):172-181.
    View in: PubMed
    Score: 0.104
  25. Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers. Nicotine Tob Res. 2015 Jul; 17(7):855-61.
    View in: PubMed
    Score: 0.096
  26. Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. Clin Pharmacol Ther. 2014 Aug; 96(2):256-65.
    View in: PubMed
    Score: 0.092
  27. Teaching tobacco dependence treatment and counseling skills during medical school: rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial. Contemp Clin Trials. 2014 Mar; 37(2):284-93.
    View in: PubMed
    Score: 0.091
  28. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11.
    View in: PubMed
    Score: 0.088
  29. Tobacco dependence treatment teaching by medical school clerkship preceptors: survey responses from more than 1,000 US medical students. Prev Med. 2013 Aug; 57(2):81-6.
    View in: PubMed
    Score: 0.086
  30. Biomarkers for smoking cessation. Clin Pharmacol Ther. 2013 Jun; 93(6):526-38.
    View in: PubMed
    Score: 0.085
  31. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb; 15(2):518-26.
    View in: PubMed
    Score: 0.082
  32. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J. 2012 Feb; 12(1):86-92.
    View in: PubMed
    Score: 0.071
  33. Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 2010 Mar; 11(3):357-67.
    View in: PubMed
    Score: 0.069
  34. [Smoking cessation]. Praxis (Bern 1994). 2008 Nov 05; 97(22):1185-6.
    View in: PubMed
    Score: 0.063
  35. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008 Jun; 65(6):683-93.
    View in: PubMed
    Score: 0.061
  36. Smoking cessation. BMJ. 2008 Jan 26; 336(7637):217.
    View in: PubMed
    Score: 0.060
  37. A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res. 2008 Jan; 10(1):231-40.
    View in: PubMed
    Score: 0.060
  38. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine Tob Res. 2007 12; 9(12):1251-7.
    View in: PubMed
    Score: 0.059
  39. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res. 2007 Aug; 9(8):821-33.
    View in: PubMed
    Score: 0.058
  40. Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1065-9.
    View in: PubMed
    Score: 0.057
  41. The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res. 2007 Feb; 9(2):225-31.
    View in: PubMed
    Score: 0.056
  42. Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students. Prev Med. 2015 Mar; 72:56-63.
    View in: PubMed
    Score: 0.024
  43. Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction. 2011 May; 106(5):985-94.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.